Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Syndax Pharmaceuticals (SNDX) has a market cap of $1.20 billion USD. According to our data, Syndax Pharmaceuticals is ranked No.4944 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $1.20 B |
5.90%
|
| Dec 31, 2024 | $1.13 B |
-38.82%
|
| Dec 29, 2023 | $1.84 B |
-15.09%
|
| Dec 30, 2022 | $2.17 B |
16.26%
|
| Dec 31, 2021 | $1.87 B |
-1.57%
|
| Dec 31, 2020 | $1.90 B |
153.30%
|
| Dec 31, 2019 | $0.75 B |
97.30%
|
| Dec 31, 2018 | $0.38 B |
-49.20%
|
| Dec 29, 2017 | $0.75 B |
22.18%
|
| Dec 30, 2016 | $0.61 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
 Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
 Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
 AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
 Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
 Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
 Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
 Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
 Exelixis
EXEL
|
$9.39 B |
0.000 M
|
USA
|
 Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
 BeiGene
BGNE
|
$20.21 B |
-0.311 B
|
China
|
 Zai Lab
ZLAB
|
$3.03 B |
0.125 B
|
China
|
| Market Cap | = | SNDX Stock Price | * | SNDX Shares Outstanding |
| = | $14.00 | * | 85.36 M | |
| = | $1.20 B |